Rhumbline Advisers Aurinia Pharmaceuticals Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 176,766 shares of AUPH stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176,766
Previous 193,735
8.76%
Holding current value
$2.07 Million
Previous $1.56 Million
3.85%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AUPH
# of Institutions
244Shares Held
62.4MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$117 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$109 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$46.5 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$32.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$28.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.66B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...